ScholarIQanswers from OpenAlex

Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation

PaperCitations, authors & open-access status

Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation have?

ScholarIQcitation count

Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation has 98 citations in the OpenAlex counts ScholarIQ stores.

When was Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation published?

ScholarIQyear

Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation has 2019 year in the ScholarIQ index.

What is the open-access status of Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation?

ScholarIQoa status

Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation has closed oa status in the ScholarIQ index.

What is the DOI of Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation?

ScholarIQdoi

The DOI for Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation is on the source record.

What is the PMID of Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation?

ScholarIQpmid

The PMID for Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation is on the source record.

What is the OpenAlex record for Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation?

ScholarIQopenalex

The OpenAlex for Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial